Canada Life
CUE icon

Canada Life’s Cue Biopharma CUE Stock Holding History

Canada Life’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40
Closed -$6K – 2437
2022
Q1 		$6K Hold
40
– – ﹤0.01% 2461
2021
Q4 		$13K Hold
40
– – ﹤0.01% 2425
2021
Q3 		$18K Hold
40
– – ﹤0.01% 2449
2021
Q2 		$14K Hold
40
– – ﹤0.01% 2523
2021
Q1 		$14K Hold
40
– – ﹤0.01% 2541
2020
Q4 		$15K Hold
40
– – ﹤0.01% 2569
2020
Q3 		$18K Hold
40
– – ﹤0.01% 2460
2020
Q2 		$29K Buy
+40
New +$29K ﹤0.01% 2407

Other funds holding CUE

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Canada Life's CUE Position: Q2 2022 in Review

Canada Life sold out of Cue Biopharma (CUE) in Q2 2022, closing a stake of 40 shares — an estimated $6K sold.

Canada Life first reported a position in CUE in Q2 2020 and held it in 8 quarters. The position peaked at $29K in Q2 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2022.

  • Canada Life reported no remaining Cue Biopharma position as of Q2 2022 after selling out during the quarter.
  • Canada Life sold 40 Cue Biopharma shares in Q2 2022, an estimated $6K.
  • Canada Life first reported a position in Cue Biopharma in Q2 2020 and held it in 8 quarters.
  • Canada Life's Cue Biopharma position peaked at $29K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.